AONN+ Takes a Seat at the Table of the Biden Cancer Initiative

May 2018 Vol 9, No 5
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Editor-in-Chief, JONS; Co-Founder, AONN+; University Distinguished Service Professor of Breast Cancer, Administrative Director, The Johns Hopkins Breast Center; Director, Johns Hopkins Cancer Survivorship Programs; Professor of Surgery and Oncology, JHU School of Medicine; Co-Creator, Work Stride-Managing Cancer at Work

Dear Navigators, Social Workers, Administrators, and Clinical Staff,

The Biden Cancer Initiative builds on former Vice President Joe Biden’s work on the National Cancer Moonshot Initiative by developing and driving implementation of solutions to accelerate progress in cancer prevention, detection, diagnosis, research, and care, and to reduce disparities in cancer outcomes. To fulfill this mission, the initiative is working closely with patients and patient organizations, cancer researchers, cancer centers, research universities, governments, and the private and philanthropic sectors.

The Academy of Oncology Nurse & Patient Navigators (AONN+) had a strong presence at the first of the Biden Cancer Initiative’s “Conversations with Dr. Biden,” held March 10, 2018, in Austin, TX. Hosted by Jill Biden, MEd, Co-chair of the Biden Cancer Initiative, these conversations are being held across the country in intimate community settings to provide members of the patient support network—families, caregivers, patient navigators, and others—with the opportunity to share their perspectives on the cancer journey.

Of the 10 people who participated in the event, several were AONN+ members, including Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning and Initiatives, The Lynx Group, who sits on the Biden Cancer Initiative’s Advisory Committee. It is Ms Johnston’s hope that by leveraging the navigator network of AONN+ and bringing them to the table for events such as “Conversations with Dr. Biden,” she will further the mission of AONN+ to advance the role of patient navigation in the cancer care continuum.

Speaking on behalf of all of us at AONN+, we are proud to be a part of the Biden Cancer Initiative’s programs. Quality cancer care cannot be achieved without effective navigation, patient advocacy, and the combined efforts of a multidisciplinary team working together on behalf of the patient.

For more about the Biden Cancer Initiative, please visit BidenCancer.org.

Sincerely,

Lillie Digital Signature

Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+
University Distinguished Professor of Breast Cancer, Adm Director, the Johns Hopkins Breast Center; Director, Johns Hopkins Cancer Survivorship Programs; Professor of Surgery and Oncology, JHU School of Medicine; Co-Creator, Work Stride-Managing Cancer at Work

This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles
Top 10 Reasons to Attend the AONN+ Midyear Conference
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
|
March 2020 Vol 11, No 3
Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes
Web Exclusives
Pivotal phase 3 data demonstrated treatment with luspatercept resulted in statistically significant increased red blood cell transfusion independence compared with placebo.
FDA Grants Priority Review to New Drug Application for the RET Kinase Inhibitor Selpercatinib
Web Exclusives
On January 29, 2020, Eli Lilly announced that the FDA granted priority review to their New Drug Application for selpercatinib (LOXO-292) for the treatment of patients with advanced RET fusion-positive non–small-cell lung cancer, RET-mutant medullary thyroid cancer, and RET fusion-positive thyroid cancer. The FDA is aiming to provide its decision on the approval of selpercatinib in the third quarter of 2020.
Cite this Article
Journal of Oncology Navigation & Survivorship. 2018;9:180.
Last modified: February 25, 2020

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code